 |
|
Problems in the Use of Serologic Tests for the Diagnosis of Lyme Disease
Marilou Corpuz, MD;
Eileen Hilton, MD;
M. Peter Lardis;
Carol Singer, MD;
John Zolan, MS
Arch Intern Med. 1991;151(9):1837-1840.
Abstract
| |
Lyme disease can be reliably diagnosed in the presence of erythema migrans. When erythema migrans is absent, serologic tests are often used to confirm the diagnosis. To choose a test for our Lyme disease diagnostic center, serum samples were obtained from 34 patients and tested for antibodies to Borrelia burgdorferi. We evaluated five enzyme-linked immunosorbent assays from Stony Brook (NY) University Hospital, Cambridge Bioscience (Worcester, Mass), Hillcrest Biologicals (Cypress, Calif), Sigma Diagnostics (St Louis, Mo), and Zeus-Wampole Scientific Inc (Raritan, NJ) and two fluorescent antibody tests (3M [Diagnostic Systems Inc, Santa Clara, Calif] and FIAX [Whittaker M.A. Bioproducts Inc, Walkersville, Md]) A positive sample by any test was further analyzed by Western blot. Using the Centers for Disease Control (Atlanta, Ga) epidemiologic case definitions, patients were classified into those with clinical Lyme disease, patients not meeting the Centers for Disease Control definitions, and asymptomatic patients. Sensitivities of Lyme serologies varied from 13% to 73%, with Hillcrest showing the highest value and Sigma the lowest value. False-positive test results were found in 0% to 27% of patients. Western blot analysis was positive in six of 15 patients with clinical Lyme disease. These results emphasize the need for better serologic testing for Lyme disease and underline their usefulness only as adjuncts in the clinical diagnosis of Lyme disease.
(Arch Intern Med. 1991;151:1837-1840)
Author Affiliations
From the Division of Infectious Diseases, Department of Medicine, Long Island Jewish Medical Center, Long Island Campus for Albert Einstein College of Medicine, New Hyde Park, NY.
Footnotes
Accepted for publication April 8, 1991.
Presented in part at the Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, Ga, October 24, 1990.
Reprint requests to Long Island Jewish Medical Center, Lakeville Road, Room B 202, New Hyde Park, NY 11042 (Dr Hilton).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Lyme disease and optic neuritis: Long-term follow-up of seropositive patients
Jacobson
Neurology 2003;60:881-882.
FULL TEXT
Identifying Diagnostic Peptides for Lyme Disease through Epitope Discovery
Kouzmitcheva et al.
CVI 2001;8:150-160.
ABSTRACT
| FULL TEXT
Ruling Out or Ruling In Disease with the Most sensitiue or Specific Diagnostic Test: Short Cut or Wrong Turn ?
Boyko
Med Decis Making 1994;14:175-179.
ABSTRACT
Physician Beliefs, Attitudes, and Approaches Toward Lyme Disease in an Endemic Area
Eppes et al.
CLIN PEDIATR 1994;33:130-134.
ABSTRACT
False Positive
Cameron
Arch Intern Med 1992;152:1331-1331.
ABSTRACT
False Positive-Reply
Singer et al.
Arch Intern Med 1992;152:1331-1331.
ABSTRACT
|
